Human Cytochromes P450 Associated with the Phase 1 Metabolism of Drugs and other Xenobiotics: A Compilation of Substrates and Inhibitors of the CYP1, CYP2 and CYP3 Families

By  

Current Medicinal Chemistry, Vol. 10, Iss. 19, 2003-10 ,pp. : 1955-1972

Bentham Science Publishers

Access to resources Recommend Favorite

Drugs as CYP3A Probes, Inducers, and Inhibitors

By Liu Yi-Tong   Hao Hai-Ping   Liu Chang-Xiao   Wang Guang-Ji   Xie Hong-Guang  

Drug Metabolism Reviews, Vol. 39, Iss. 4, 2007-10 ,pp. : 699-721

Informa Healthcare

Access to resources Recommend Favorite

The Functional Role of CYP2B6 in Human Drug Metabolism: Substrates and Inhibitors In Vitro, In Vivo and In Silico

By  

Current Drug Metabolism, Vol. 7, Iss. 7, 2006-10 ,pp. : 705-714

Bentham Science Publishers

Access to resources Recommend Favorite

Concomitant use of erythromycin + CYP3A inhibitors should be avoided

By  

Inpharma, Vol. 1, Iss. 1455, 2004-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Risk Management of Simvastatin or Atorvastatin Interactions with CYP3A4 Inhibitors

By Molden Espen  

Drug Safety, Vol. 31, Iss. 7, 2008-01 ,pp. : 587-596

Adis International

Access to resources Recommend Favorite